Delivery Order SPE2DB22D1041-SPE2DB25FTZE2
Award Date
1/21/25
Potential Completion Date
1/22/25
Potential Value
$6K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of Quillivant XR 25 mg/5 ml oral suspension in 60 ml bottles. The contract has a firm fixed price of $1,524.36 and a completion date of September 11, 2024. It is not a set-aside contract. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,598.73 contract is for the supply of Quillivant XR 25 mg/5 ml suspension, a prescription medication. The contract has a period of performance through March 3, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, which...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,723.68, is for the supply of Quillivant XR 25 mg/5 ml suspension in 120 ml bottles. The contract has a firm fixed price structure and an ultimate completion date of May 22, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,314.20, is a Firm Fixed Price Delivery Order for the supply of Quillivant XR 25 mg/5 ml suspension, a pharmaceutical product. The contract has an ultimate completion date of January 21, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Quillivant XR 25 mg/5 ml suspension in 150 ml bottles. The contract is a firm fixed-price delivery order with a ceiling value of $2,908.44 and a period of performance through March 6, 2025. The award is not associated with a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Quillivant XR 25 mg/5 ml suspension in 180 ml bottles. The contract has a ceiling value of $4,528.40 and runs through February 10, 2025. It is a firm fixed-price delivery order contract with no set-aside designation, indicating open competition. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Quillivant XR 25 mg/5 ml suspension medication. The contract, valued at $1,064.59, has a firm fixed price and runs through March 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999, which serves...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,051.36, is for the delivery of the drug Quillivant XR 25 mg/5 ml suspension in 180 ml containers. This is a Firm Fixed Price delivery order contract with an ultimate completion date of April 4, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the drug Quillivant XR (25 mg/5 ml suspension, 120 ml). The contract has a ceiling value of $1,693.82 and is a firm fixed-price delivery order with a completion date of February 24, 2025. This contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award, valued at $1,156.50, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Quillivant XR, a 25 mg/5 ml suspension medication, with a completion date of May 8, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type, and there is no set-aside designation indicated. AmerisourceBergen holds a significant Indefinite...